Pharma Mar Competitors and Similar CompaniesClear all

Pharma Mar's competitors and similar companies include Castle Biosciences, Bioiberica, BioInvent and Inventiva.
Pharma Mar
Pharma Mar
Pharma Mar is a biopharmaceutical company that engages in the discovery and development of marine-derived anticancer drugs.
Castle Biosciences
Castle Biosciences
Castle Biosciences is a company developing and commercializing diagnostic and prognostic tests for dermatologic cancers.
Bioiberica
Bioiberica
Bioiberica is a life science company engaged in the identification, extraction, and development of animal-derived biomolecules.
BioInvent
BioInvent
BioInvent focuses on the discovery and development of antibody-based drugs against cancer.
Inventiva
Inventiva
Inventiva is a clinical stage biopharmaceutical company with an expertise in fibrosis, oncology and orphan diseases.
Founding Date
Founding Date
1986
Founding Date
2008
Founding Date
1975
Founding Date
1997
Founding Date
2011
Type
Type
Public
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Tags
Locations
Locations
Colmenar Viejo, ES HQ
Madrid, ES
Locations
Friendswood, US HQ
Phoenix, US
Locations
Esplugues de Llobregat, ES HQ
Barcelona, ES
Palafolls, ES
Locations
Lund, SE HQ
Locations
Daix, FR HQ
Employees
Employees
500
Employees
61013% increase
Employees
332
Employees
118
Employees
114
Valuation ($)
Valuation ($)
1.4 b
Valuation ($)
936.9 m
Valuation ($)
N/A
Valuation ($)
285.9 m
Valuation ($)
231 m

Financial

Revenue (est.)
Revenue (est.)
€221.4m (FY, 2025)
Revenue (est.)
$344.2m (FY, 2025)
Revenue (est.)
$346.7m (FY, 2018)
Revenue (est.)
kr226.5m (FY, 2025)
Revenue (est.)
€4.5m (FY, 2025)
Cost of goods
Cost of goods
€12.3m (FY, 2025)
Cost of goods
$71m (FY, 2025)
Cost of goods
$190.3m (FY, 2018)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
€232m (FY, 2025)
Gross profit
$273.2m (FY, 2025)
Gross profit
$156.4m (FY, 2018)
Gross profit
kr226.6m (FY, 2025)
Gross profit
€7.9m (FY, 2025)
Net income
Net income
€75m (FY, 2025)
Net income
($24.2m) (FY, 2025)
Net income
$40.5m (FY, 2018)
Net income
(kr332.9m) (FY, 2025)
Net income
(€354.1m) (FY, 2025)

Operating

Patent Applications
Patent Applications
N/A
Patent Applications
39 (FY, 2021)
Patent Applications
50 (Apr, 2020)
Patent Applications
N/A
Patent Applications
N/A
For sources of this data, please see the company profile

View Company Profiles

Castle Biosciences
HQ
Friendswood, US
Employees
610↑ 13% increase

Castle Biosciences is a company developing and commercializing diagnostic and prognostic tests for dermatologic cancers.

View company
Bioiberica
HQ
Esplugues de Llobregat, ES

Bioiberica is a life science company engaged in the identification, extraction, and development of animal-derived biomolecules.

View company
BioInvent
HQ
Lund, SE
Employees
118

BioInvent focuses on the discovery and development of antibody-based drugs against cancer.

View company
Inventiva
HQ
Daix, FR
Employees
114

Inventiva is a clinical stage biopharmaceutical company with an expertise in fibrosis, oncology and orphan diseases.

View company